NO EVIDENCE OF LINKAGE BETWEEN SCHIZOPHRENIA AND D(3) DOPAMINE RECEPTOR GENE LOCUS IN ICELANDIC PEDIGREES

被引:41
作者
WIESE, C
LANNFELT, L
KRISTBJARNARSON, H
YANG, L
ZOEGA, T
SOKOLOFF, P
IVARSSON, O
SCHWARTZ, JC
MOISES, HW
HELGASON, T
机构
[1] KIEL UNIV HOSP, DEPT PSYCHIAT, MOLEC GENET LAB, NIEMANNSWEG 147, W-2300 KIEL 1, GERMANY
[2] INSERM, UNITE NEUROBIOL, F-75005 PARIS, FRANCE
[3] NATL UNIV HOSP REYKJAVIK, DEPT PSYCHIAT, REYKJAVIK, ICELAND
[4] JINAN UNIV, FAC MED, DEPT MICROBIOL & IMMUNOL, Guangzhou, PEOPLES R CHINA
[5] UNIV PARIS 05, F-75270 PARIS 06, FRANCE
[6] INSERM, UNITE NEUROBIOL & PHARMACOL, F-75005 PARIS, FRANCE
[7] UNIV KIEL, FAC MED, W-2300 KIEL 1, GERMANY
[8] NATL UNIV REYKJAVIK, FAC MED, REYKJAVIK, ICELAND
关键词
GENETICS; LINKAGE; DRD3; SCHIZOAFFECTIVE PSYCHOSIS; MAJOR DEPRESSION;
D O I
10.1016/0165-1781(93)90009-6
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The D3 dopamine receptor gene is an important candidate gene for schizophrenia, since-because of its almost exclusive expression in the limbic system-it combines the dopamine receptor hypothesis with the limbic system hypothesis of schizophrenia. Pairwise linkage analyses were carried out between the D3 dopamine receptor gene locus (DRD3) and schizophrenia (including major depression among its pleiotropic manifestations). On the basis of these analyses, which assumed a penetrance of 0.71 and a dominant mode of inheritance, we were able to exclude the DRD3 locus with a lod score of -2.50 in four Icelandic pedigrees. The area of exclusion (lod score < -2.00) extended 1.2 centimorgans. We conclude that the genetic predisposition to schizophrenia in these pedigrees is not due to a mutation in the DRD3 locus. However, these results cannot exclude the possibility that a defect in other genes regulating the expression of the D3 dopamine receptor gene could be involved in the pathogenesis of schizophrenia or that linkage analyses in other families or population-based association studies might show a positive result.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 58 条
[1]  
ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856
[2]  
ANDREASEN NC, 1987, ARCH GEN PSYCHIAT, V44, P461
[3]   CLASSIFICATION OF SCHIZO-AFFECTIVE PATIENTS BY MULTIDIMENSIONAL-SCALING AND CLUSTER-ANALYSIS [J].
ANGST, J ;
SCHARFETTER, C ;
STASSEN, HH .
PSYCHIATRIA CLINICA, 1983, 16 (2-4) :254-264
[4]   SCHIZOPHRENIA AND AFFECTIVE-DISORDER - ARE THEY GENETICALLY LINKED [J].
BARON, M ;
GRUEN, RS .
BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 :267-270
[5]  
BARON M, 1985, AM J PSYCHIAT, V142, P447
[6]   LOCALIZATION OF DOPAMINE-D3 RECEPTOR MESSENGER-RNA IN THE RAT-BRAIN USING INSITU HYBRIDIZATION HISTOCHEMISTRY - COMPARISON WITH DOPAMINE-D2 RECEPTOR MESSENGER-RNA [J].
BOUTHENET, ML ;
SOUIL, E ;
MARTRES, MP ;
SOKOLOFF, P ;
GIROS, B ;
SCHWARTZ, JC .
BRAIN RESEARCH, 1991, 564 (02) :203-219
[7]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[8]   THE CURRENT STATUS OF THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA [J].
CARLSSON, A .
NEUROPSYCHOPHARMACOLOGY, 1988, 1 (03) :179-186
[9]   DOPAMINE RECEPTOR-BINDING PREDICTS CLINICAL AND PHARMACOLOGICAL POTENCIES OF ANTI-SCHIZOPHRENIC DRUGS [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
SCIENCE, 1976, 192 (4238) :481-483